|
Squamous cell carcinoma of the head and neck
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Of 34 informative cases of head and neck squamous cell carcinoma, 68% of tumors showed loss of heterozygosity at chromosome 13q33-34, where the ING1 gene is located.
|
10866301 |
2000 |
|
Squamous cell carcinoma of the head and neck
|
0.710 |
Biomarker
|
disease |
BEFREE |
Because ING1 resides on the long arm of chromosome 13 (13q34) (a region frequently deleted in many tumor types), we sought to characterize its role in head and neck squamous-cell carcinoma (HNSCC).
|
10679922 |
2000 |
|
Squamous cell carcinoma of the head and neck
|
0.710 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
|
Squamous cell carcinoma of the head and neck
|
0.710 |
Biomarker
|
disease |
CTD_human |
|
|
|
|
Squamous cell carcinoma of the head and neck
|
0.710 |
CausalMutation
|
disease |
CGI |
|
|
|
|
Malignant neoplasm of stomach
|
0.320 |
Biomarker
|
disease |
CTD_human |
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
|
21364753 |
2011 |
|
Malignant neoplasm of stomach
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
However, there has been no report on the prognostic significance of the ING1 expression level in human cancers, though the expression of the wild-type ING1 gene is significantly decreased in breast, lymphoid and gastric cancers as compared with their corresponding normal tissues.
|
15375504 |
2004 |
|
Malignant neoplasm of stomach
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
A significant decrease in p33(ING1) expression was evident in 15 of 20 gastric cancers.
|
10660101 |
1999 |
|
Contact Dermatitis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay.
|
25724174 |
2015 |
|
Contact hypersensitivity
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay.
|
25724174 |
2015 |
|
Stomach Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
|
21364753 |
2011 |
|
Disease Exacerbation
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
|
21364753 |
2011 |
|
Hereditary Diffuse Gastric Cancer
|
0.300 |
Biomarker
|
disease |
CTD_human |
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
|
21364753 |
2011 |
|
Squamous cell carcinoma of lip
|
0.300 |
SomaticCausalMutation
|
disease |
ORPHANET |
Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas.
|
10866301 |
2000 |
|
Squamous cell carcinoma of oropharynx
|
0.300 |
SomaticCausalMutation
|
disease |
ORPHANET |
Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas.
|
10866301 |
2000 |
|
Squamous cell carcinoma of the hypopharynx
|
0.300 |
SomaticCausalMutation
|
disease |
ORPHANET |
Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas.
|
10866301 |
2000 |
|
Laryngeal Squamous Cell Carcinoma
|
0.300 |
SomaticCausalMutation
|
disease |
ORPHANET |
Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas.
|
10866301 |
2000 |
|
Squamous cell carcinoma of mouth
|
0.300 |
SomaticCausalMutation
|
disease |
ORPHANET |
Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas.
|
10866301 |
2000 |
|
Squamous cell carcinoma
|
0.160 |
Biomarker
|
disease |
BEFREE |
Nuclear entrapment of p33ING1b by inhibition of exportin-1: A trigger of apoptosis in head and neck squamous cell cancer.
|
29729696 |
2018 |
|
Squamous cell carcinoma
|
0.160 |
Biomarker
|
disease |
LHGDN |
Nuclear to cytoplasmic shift of p33(ING1b) protein from normal oral mucosa to oral squamous cell carcinoma in relation to clinicopathological variables.
|
17805569 |
2008 |
|
Squamous cell carcinoma
|
0.160 |
AlteredExpression
|
disease |
BEFREE |
GAPDH mRNA expression was detectable in 12 out of 21 oral squamous cell carcinoma (SCC) samples. p21WAF1 mRNA expression was detectable in 5 out of 12 SCC samples, MDM2 mRNA expression was detectable in 5 our of 12 SCC samples and p33ING1 mRNA expression was detectable in 6 out of 12 SCC samples.
|
12926130 |
2003 |
|
Squamous cell carcinoma
|
0.160 |
AlteredExpression
|
disease |
BEFREE |
Twenty-six of 28 oral squamous cell carcinomas (SCCs) expressed p33ING1 mRNA.
|
12063558 |
2002 |
|
Squamous cell carcinoma
|
0.160 |
Biomarker
|
disease |
BEFREE |
Mutational analysis of the candidate tumor suppressor gene ING1 in Indian oral squamous cell carcinoma.
|
11287275 |
2001 |
|
Squamous cell carcinoma
|
0.160 |
GeneticVariation
|
disease |
BEFREE |
Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas.
|
10866301 |
2000 |
|
Squamous cell carcinoma
|
0.160 |
Biomarker
|
disease |
HPO |
|
|
|